The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.

MLA

Li, Mengmeng, et al. “The Influence of Postscreening Follow-up Time and Participant Characteristics on Estimates of Overdiagnosis from Lung Cancer Screening Trials.” International Journal of Cancer, vol. 151, no. 9, Nov. 2022, pp. 1491–501. EBSCOhost, https://doi.org/10.1002/ijc.34167.

APA

Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., Kaaks, R., Johansson, M., Carvalho, A. L., Vaccarella, S., & Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer, 151(9), 1491–1501. https://doi.org/10.1002/ijc.34167

Chicago

Li, Mengmeng, Li Zhang, Hadrien Charvat, Matthew E Callister, Peter Sasieni, Evangelia Christodoulou, Rudolf Kaaks, et al. 2022. “The Influence of Postscreening Follow-up Time and Participant Characteristics on Estimates of Overdiagnosis from Lung Cancer Screening Trials.” International Journal of Cancer 151 (9): 1491–1501. doi:10.1002/ijc.34167.